These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 2536469)

  • 1. Immunization against prostaglandins reduces delta 1-tetrahydrocannabinol-induced catalepsy in mice.
    Burstein SH; Hull K; Hunter SA; Shilstone J
    Mol Pharmacol; 1989 Jan; 35(1):6-9. PubMed ID: 2536469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
    Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
    Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of 5-hydroxytryptamine1A receptors in Delta9-tetrahydrocannabinol-induced catalepsy-like immobilization in mice.
    Egashira N; Matsuda T; Koushi E; Mishima K; Iwasaki K; Shoyama Y; Fujiwara M
    Eur J Pharmacol; 2006 Nov; 550(1-3):117-22. PubMed ID: 17022969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic factors in sex differences in Delta 9-tetrahydrocannabinol-induced behavioral effects in rats.
    Tseng AH; Harding JW; Craft RM
    Behav Brain Res; 2004 Sep; 154(1):77-83. PubMed ID: 15302113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A major metabolite of delta 1-tetrahydrocannabinol reduces its cataleptic effect in mice.
    Burstein S; Hunter SA; Latham V; Renzulli L
    Experientia; 1987 Apr; 43(4):402-3. PubMed ID: 3032669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delta 9-tetrahydrocannabinol injection induces cytokine-mediated mortality of mice infected with Legionella pneumophila.
    Klein TW; Newton C; Widen R; Friedman H
    J Pharmacol Exp Ther; 1993 Nov; 267(2):635-40. PubMed ID: 7504099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of endogenous opioids in enhancing the antinociception produced by the combination of delta 9-tetrahydrocannabinol and morphine in the spinal cord.
    Pugh G; Smith PB; Dombrowski DS; Welch SP
    J Pharmacol Exp Ther; 1996 Nov; 279(2):608-16. PubMed ID: 8930163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of brain prostaglandin E2 levels in rodents by delta 1-tetrahydrocannabinol.
    Hunter SA; Audette CA; Burstein S
    Prostaglandins Leukot Essent Fatty Acids; 1991 Jul; 43(3):185-90. PubMed ID: 1651514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the agonistic activity of delta 9-11-tetrahydrocannabinol in mice, dogs and rhesus monkeys and its interactions with delta 9-tetrahydrocannabinol.
    Beardsley PM; Scimeca JA; Martin BR
    J Pharmacol Exp Ther; 1987 May; 241(2):521-6. PubMed ID: 3033218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of Delta9-tetrahydrocannabinol-induced MCF-7 breast cancer cell growth by cyclooxygenase and aromatase.
    Takeda S; Yamamoto I; Watanabe K
    Toxicology; 2009 May; 259(1-2):25-32. PubMed ID: 19428940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of delta 9-tetrahydrocannabinol on prostaglandin formation in brain.
    Reichman M; Nen W; Hokin LE
    Mol Pharmacol; 1987 Nov; 32(5):686-90. PubMed ID: 2824983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTP Toxicology and Carcinogenesis Studies of 1-Trans-Delta(9)-Tetrahydrocannabinol (CAS No. 1972-08-3) in F344 Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Nov; 446():1-317. PubMed ID: 12594529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The oral activity of delta'-tetrahydrocannabinol and its dependence on prostaglandin E2.
    Fairbairn JW; Pickens JT
    Br J Pharmacol; 1979 Nov; 67(3):379-85. PubMed ID: 574040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted deletion of cannabinoid receptors CB1 and CB2 produced enhanced inflammatory responses to influenza A/PR/8/34 in the absence and presence of Delta9-tetrahydrocannabinol.
    Buchweitz JP; Karmaus PW; Williams KJ; Harkema JR; Kaminski NE
    J Leukoc Biol; 2008 Mar; 83(3):785-96. PubMed ID: 18073275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic disposition of delta 8-tetrahydrocannabinol and its active metabolites, 11-hydroxy-delta 8-tetrahydrocannabinol and 11-oxo-delta 8-tetrahydrocannabinol, in mice.
    Watanabe K; Yamamoto I; Oguri K; Yoshimura H
    Drug Metab Dispos; 1981; 9(3):261-4. PubMed ID: 6113937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-1 beta and TNF alpha modulate delta 9-tetrahydrocannabinol-induced catalepsy in mice.
    Gibertini M; Newton C; Friedman H; Klein TW
    Pharmacol Biochem Behav; 1995 Feb; 50(2):141-6. PubMed ID: 7740051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a monoclonal antibody that neutralizes the activity of prostaglandin E2.
    Mnich SJ; Veenhuizen AW; Monahan JB; Sheehan KC; Lynch KR; Isakson PC; Portanova JP
    J Immunol; 1995 Nov; 155(9):4437-44. PubMed ID: 7594605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. delta 9-Tetrahydrocannabinol decreases turnover of brain histamine.
    Oishi R; Itoh Y; Nishibori M; Saeki K
    J Pharmacol Exp Ther; 1985 Feb; 232(2):513-8. PubMed ID: 2578567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of airway responses to influenza A/PR/8/34 by Delta9-tetrahydrocannabinol in C57BL/6 mice.
    Buchweitz JP; Karmaus PW; Harkema JR; Williams KJ; Kaminski NE
    J Pharmacol Exp Ther; 2007 Nov; 323(2):675-83. PubMed ID: 17726158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marijuana smoke and Delta(9)-tetrahydrocannabinol promote necrotic cell death but inhibit Fas-mediated apoptosis.
    Sarafian TA; Tashkin DP; Roth MD
    Toxicol Appl Pharmacol; 2001 Aug; 174(3):264-72. PubMed ID: 11485387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.